跳至主要内容
临床试验/CTRI/2023/03/051044
CTRI/2023/03/051044尚未招募2 期

To Study the Efficacy of Vaskadikwath in Pramehjanya Timir with special Reference to Non Proliferative Diabetic Retinopathy

Government Ayurvedic College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients type2 Non Insulin Dependent Diabetes with or without visual disturbance but detectable opthalmosope features of Diabetic Retinopathy with blood level FBS 126 to 220mg/dl or PPBS 170 to 330mg/dl with ongoing treatment
  • Early stage of NPDR

排除标准

  • Patients who are extremely debilitating and those who are not withstand treatment procedure
  • High risk Diabetic Retinopathy or those requiring emergency intervention
  • Patients of Diabetic Retinopathy with media opacities like cataract vitreous degeneration etc with interfere with opthalmosopical finding
  • Patients having other ocular like glaucoma High myopia
  • Hypertensive Retinopathy and Diabetic Retinopathy associated with pregnancy
  • Patients who BCVA is less than 6/60

研究者

发起方
Government Ayurvedic College and Hospital

相似试验